# ORIC Filing Lists -$0.38 Per-Share Loss for June Quarter

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/58829
Published: 2026-11-16T21:38:54.000Z
Updated: 2026-11-16T21:38:54.000Z
Section: Business

> The Aug. 3 filing gave the same net loss per share for basic and diluted calculations for the quarter ended June 30, 2026.

ORIC Pharmaceuticals’ quarterly filing dated Aug. 3 lists net loss per share of -$0.38, both basic and diluted, for the quarter ended June 30, 2026.


